Paternal and maternal urinary phthalate metabolite concentrations and birth weight of singletons conceived by

Carmen Messerlian1, Joseph M Braun2, Lidia Mínguez-Alarcón1

  • 1Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Insights

Paternal exposure to certain phthalates before conception may lower infant birth weight, particularly for in-vitro fertilization (IVF) conceived babies. This highlights the importance of parental preconception health for successful pregnancy outcomes.

Area of Science:

  • Environmental health
  • Reproductive toxicology
  • Perinatal epidemiology

Background:

  • Prenatal phthalate exposure is inconsistently linked to fetal growth and birth weight.
  • The impact of paternal and maternal preconception phthalate exposure on birth weight is understudied.

Purpose of the Study:

  • To investigate associations between paternal/maternal preconception and maternal prenatal phthalate metabolite concentrations and birth weight.
  • To examine these associations separately for in-vitro fertilization (IVF) and non-IVF conception.

Main Methods:

  • Prospective cohort study (EARTH Study) of 364 couples.
  • Measured urinary phthalate metabolites in maternal and paternal preconception and maternal prenatal samples.
  • Used multivariable linear regression to assess associations with birth weight, adjusting for covariates and by mode of conception.

Main Results:

  • Paternal preconception urinary sum of di(2-ethylhexyl) phthalate (ΣDEHP) metabolites was associated with a 90g decrease in birth weight for IVF singletons.
  • No significant association was observed for non-IVF singletons.
  • Maternal prenatal phthalate associations with birth weight were attenuated after adjusting for paternal phthalates.

Conclusions:

  • Paternal preconception ΣDEHP metabolite concentration is linked to reduced birth weight in IVF-conceived singletons.
  • Findings underscore the significance of preconception health, particularly for subfertile couples.
  • Further research is needed to replicate these findings.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Probability Laws01:49

Probability Laws

Overview
44.7K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.2K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
37.8K